GGrantIndex
Sort

64,565 grants matching drug discovery

Integrated Antimicrobial Drug Discovery Scheme for Multidrug Resistant Bacteria

$677,062
Zoltan N. Oltvai · University Of Pittsburgh At Pittsburgh · U01 · FY2007 · AI

Development of Kv3.1 potentiators for correcting fast-spiking-interneuron hypofunction in schizophrenia and autism spectrum disorder

$677,025
Jerod S Denton · Vanderbilt University Medical Center · R01 · FY2024 · MH

Modulation of epigenetic programming of tissue resident macrophage lineages to impact HIV-1 infection, maintenance, and persistence.

$676,923
David G Russell · Cornell University · R01 · FY2024 · AI

Skeletal Muscle Loss and Dysfunction

$676,889
Nathan K Lebrasseur · Mayo Clinic Rochester · P01 · FY2021 · AG

Clinical Development Research Career Development Program

$676,755
Massachusetts General Hospital · K12 · FY2004 · CA

Clinical Development Research Career Development Program

$676,755
Massachusetts General Hospital · K12 · FY2005 · CA

Mechanisms of Endogenous DNA Damage Promotion

$676,743
Susan M. Rosenberg · Baylor College Of Medicine · R01 · FY2020 · CA

4/4 The Autism Sequencing Consortium: Autism gene discovery in >20,000 exomes

$676,656
Matthew W State · University Of California, San Francisco · U01 · FY2015 · MH

T7 RNA polymerase engineering and RNA amplification

$676,625
Andrew D Ellington · Accacia International, Inc. · R42 · FY2008 · GM

Design and development of HDAC11-specific chemical inhibitors for disease treatments

$676,591
Edward Seto · George Washington University · R01 · FY2025 · AI

Synthetic biology tools for scalable production of medicinal plant terpenes

$676,547
Elizabeth Susan Sattely · Stanford University · R01 · FY2022 · AT

Molecular modeling of G protein-coupled receptors

$676,538
Stefano Costanzi · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK

Assembly and export of mycobacterial lipoglycans

$676,504
Mary Jackson · Colorado State University · R01 · FY2021 · AI

Indiana University Center for Pediatric Pharmacology and Precision Medicine

$676,502
Jamie L Renbarger · Indiana University Indianapolis · P50 · FY2020 · HD

Positive Allosteric Modulators as PET Imaging Ligans for mGluR4

$676,472
Anna-Liisa Brownell · Massachusetts General Hospital · R01 · FY2020 · NS

Pathophysiological Actions of Anthrax Virulence Determinants

$676,462
Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

Molecular mechanisms of bacterial homologs of neurotransmitter:sodium symporters

$676,431
Jonathan A Javitch · Columbia University Health Sciences · R01 · FY2009 · DA

Regulation of manganese homeostasis and detoxification by SLC30A10

$676,420
Somshuvra Mukhopadhyay · University Of Texas At Austin · R01 · FY2019 · ES

Leadership, Planning, and Evaluation

$676,378
Stanton L Gerson · Case Western Reserve University · P30 · FY2019 · CA

Drug Development for Prostate Cancer and other Metastatic Processes

$676,338
William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Signal Transduction by Tyrosine Phosphorylation

$676,298
Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2011 · CA

Characterization of novel regulators of embryonic stem cell self-renewal

$676,268
Guang Hu · National Institute Of Environmental Health Sciences · ZIA · FY2010 · ES

Using Integrative Genomics To Identify and Characterize Emphysema-Associated eQTL

$676,250
Peter Castaldi · Brigham And Women'S Hospital · R01 · FY2021 · HL

JAK-STAT Inhibition to Reduce Racial Disparities in Kidney Disease

$676,165
Opeyemi Ayodeji Olabisi · Duke University · R01 · FY2021 · MD

PHARMACOGENOMICS OF ACAMPROSATE TREATMENT OUTCOME

$676,116
Victor M. Karpyak · Mayo Clinic Rochester · U01 · FY2021 · AA